Cathay General Bancorp heads into May with its strongest month in over a year behind it — yet analysts watching the stock most closely aren't entirely convinced the move has further to run.
The stock rose 4% on the week to close at $55.73, capping a 14% gain in April. The rebound followed a solid Q1 print on April 22, which sent shares up more than 3% the following session. Net interest margin expanded two basis points to 3.27%, and the beat was enough to trigger a round of upward analyst revisions. But the stock now trades within touching distance of the consensus target, which compresses the remaining upside significantly.
The Street's reaction after the earnings print was to raise numbers rather than raise conviction. Keefe, Bruyette & Woods lifted its target from $55 to $58 on April 23, maintaining Market Perform. Piper Sandler followed on April 27 — moving its target up from $45 to $47, but holding an Underweight rating throughout. The message from the buy-side-facing analyst community is consistent: the bank is executing, but at $55 the reward-to-risk has narrowed. The mean target of $56.40 leaves just 1.2% upside from the last close. Jefferies, which initiated with a Buy and $53 target in May 2025, is now below the current price — though that target was set at a time when the stock was trading considerably lower. The PE multiple has expanded by 0.83 turns over the past month to 9.97x. The price-to-book has moved up 0.12x over the same period to 1.13x. Neither is stretched for a mid-cap regional bank, but both are tracking higher at a pace worth monitoring.
The options market has tilted modestly more defensive in recent sessions. The put/call ratio is running above its 20-day average at 1.06, roughly one standard deviation elevated — not extreme, but a gentle lean toward protection that was absent when the PCR hit its 52-week low of 0.11 in mid-April. Short positioning is a minor factor here. Short interest in CATY is 2.2% of the free float, having crept up roughly 3% on the week and 10% over the past month. With borrowing costs at just 0.38% and the borrow market wide open — availability is loose and well off any constraining level — there is no squeeze dynamic in play. Shorts are adding at the margin, not pressing aggressively.
Insider activity from early April adds a footnote worth noting. CEO Chang Liu sold approximately $1.15 million in shares around April 1 and April 6, shortly before the earnings catalyst lifted the stock. Those sales followed the receipt of annual equity awards on the same day, a common pattern around compensation cycles. Executive Chairman Dunson Cheng also sold just over $286,000 on April 1 alongside his own award grant. Neither transaction looks unusual in isolation, but together they represent the most concentrated insider selling in the recent window. On a 90-day net basis, the company shows net positive insider share ownership of around 53,000 shares — skewed by the inbound awards.
On the closest peer comparisons, CATY clearly outpaced the group this week. COLB added 1.8% and UBSI gained just over 1%. FULT was the laggard, slipping 0.6%. The relative outperformance reflects CATY's earnings catalyst, but the gap may close as peers report through May.
The next scheduled event is May 19. With the stock now trading above several analyst targets and options buyers showing early signs of caution, the focal point from here shifts to whether Q1 margin momentum carries into Q2 — and whether loan quality trends, which saw non-performing assets nudge up to 1.01% of loans in Q1, remain contained.
See the live data behind this article on ORTEX.
Open CATY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
